TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Kappa Bioscience AS
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover |
206,355
|
173,033
|
209,575 |
Financial expenses |
15,715
|
32,766
|
11,762 |
Earnings before taxes |
47,546
|
51,421
|
61,356 |
Total assets |
332,720
|
267,129
|
204,848 |
Current assets |
151,714
|
191,680
|
137,710 |
Current liabilities |
102,895
|
68,005
|
63,693 |
Equity capital |
179,495
|
171,638
|
135,175 |
- share capital |
1,074
|
1,134
|
1,076 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency |
53.9%
|
64.3%
|
66.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
23.0%
|
29.7%
|
29.3% |
Return on assets (ROA) |
19.0%
|
31.5%
|
35.7% |
Current ratio |
147.4%
|
281.9%
|
216.2% |
Return on equity (ROE) |
26.5%
|
30.0%
|
45.4% |
Change turnover |
42,411
|
-47,834
|
65,965 |
Change turnover % | 26% | 46% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.